Eli Lilly
1,029 hedge funds and large institutions have $52.6B invested in Eli Lilly in 2014 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 349 increasing their positions, 431 reducing their positions, and 55 closing their positions.
29% more call options, than puts
Call options by funds: $579M | Put options by funds: $450M
18% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 55
6% more capital invested
Capital invested by funds: $49.5B → $52.6B (+$3.1B)
0.83% more ownership
Funds ownership: 74.75% → 75.58% (+0.83%)
0% more funds holding
Funds holding: 1,026 → 1,029 (+3)
0% more funds holding in top 10
Funds holding in top 10: 37 → 37 (0)
19% less repeat investments, than reductions
Existing positions increased: 349 | Existing positions reduced: 431
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$544M |
| 2 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
+$239M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$205M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$193M |
| 5 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$193M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IIS
Ignis Investment Services
Edinburgh,
United Kingdom
|
-$354M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$212M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$187M |
| 4 |
FAM
Fred Alger Management
New York
|
-$133M |
| 5 |
Renaissance Technologies
New York
|
-$114M |
LLY Hedge Fund Activity: Q2 2014 in Review
1,029 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q2 2014, worth a combined $52.6B — up 6.3% from $49.5B a quarter earlier.
Buyers outnumbered sellers: 65 funds opened new LLY positions and 55 closed out — a net gain of 10 holders — while 349 added to existing stakes and 431 trimmed.
The largest buyer was Norges Bank, adding an estimated $544M. The largest seller was Ignis Investment Services, exiting entirely with an estimated $354M sold.
- 1,029 institutional investors held Eli Lilly (LLY) as of Q2 2014, up from 1,026 in Q1 2014.
- Funds reported $52.6B of Eli Lilly stock for Q2 2014, up 6.3% quarter-over-quarter.
- 65 funds opened new Eli Lilly positions in Q2 2014 and 55 closed out, a net change of +10 holders.
- The largest Eli Lilly buyer in Q2 2014 was Norges Bank, an estimated $544M added.
- The largest Eli Lilly seller in Q2 2014 was Ignis Investment Services, an estimated $354M sold.
Based on aggregated 13F filings for Q2 2014.